UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported)
August 16, 2005
Advanced Nutraceuticals, Inc.
(Exact name of registrant as specified in its charter)
| | |
|---|
Texas
(State or other jurisdiction
of incorporation) | 0-26362
(Commission
File Number) | 76-0642336
(IRS Employer
Identification No.) |
106 South University Blvd., #14 Denver, CO 80209
(Address of principal executive offices) (Zip Code)
Registrant’s telephone number, including area code (303) 722-4008
INFORMATION TO BE INCLUDED IN THE REPORT
Item 2.02 Results of Operations and Financial Condition.
The Company issued a news release on August 16, 2005, a copy of which is furnished as Exhibit 99.1.
Item 7.01 Regulation FD Disclosure.
The Company issued a news release on August 16, 2005, a copy of which is furnished as Exhibit 99.1.
Item 9.01 Financial Statements and Exhibits.
99.1 News Release, dated August 16, 2005.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| |
|---|
Dated: August 16, 2005
| ADVANCED NUTRACEUTICALS, INC.
By:/s/ Jeffrey G. McGonegal
Jeffrey G. McGonegal
Senior Vice President of Finance |
